Replies to post #97527 on NanoViricides Inc. (NNVC)

[changes_iv]

KMBJN, interesting problem Dr. Anil Diwan and his team are faced with. I don't know if there is a high concentration of receptors over the worm-like Ebola virus surface area. If so, why not increase the dose for low-toxicity Ebolacide to something like a tablespoon whereby many EbolaCide nanomachines would quickly attach, and collectively envelope and destroy the Ebola virus structure, in the trillions, in a matter of hours. I know, in the mind all things are possible. Somehow I am confident Dr. Anil Diwan and his team will find the answer to the deadly problem.

Some people in West Africa have survived the virus with conventional anti-viral drugs but far more have died.

[Ubertino]

excellent post

[e-mail]
1:07 PM (45 minutes ago)

to me

Dear you

I wish that I had KMBJN’s email so I could congratulate him for that excellent post about Ebola one hour ago

We had excellent results in vitro 5 years ago but not in the animals

It turned out that the EbolaCide was chasing the sGP that circulated as chaff

As KMBJN shows, the NPC1 receptor (Nieman Pick cholesterol 1) is an excellent alternative and obviates the chaff problem. We know all about it!

This is one smart virus but the difference is that on-going research around the world has helped elucidate the nature of its defenses

I suspect that game-over for that virus is in the cards

Also, it appears the loan ranger completely missed the pun when I talked about the Bloom being off the Rose. Since responding with facts doesn’t stop certain people from complaining, maybe humor will work

Incidentally, I cleared my email signature with our representatives at the NYSE


Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

***

My bolding!